Your browser doesn't support javascript.
loading
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies.
Arashiro, Takeshi; Arima, Yuzo; Kuramochi, Jin; Muraoka, Hirokazu; Sato, Akihiro; Chubachi, Kumi; Oba, Kunihiro; Yanai, Atsushi; Arioka, Hiroko; Uehara, Yuki; Ihara, Genei; Kato, Yasuyuki; Yanagisawa, Naoki; Nagura, Yoshito; Yanai, Hideki; Ueda, Akihiro; Numata, Akira; Kato, Hideaki; Oka, Hideaki; Nishida, Yusuke; Ooki, Takao; Nidaira, Yuki; Stucky, Ashley; Suzuki, Tadaki; Smith, Chris; Hibberd, Martin; Ariyoshi, Koya; Suzuki, Motoi.
Afiliação
  • Arashiro T; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Arima Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kuramochi J; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Muraoka H; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
  • Sato A; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
  • Chubachi K; Kuramochi Clinic Interpark, Tochigi, Japan.
  • Oba K; Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yanai A; CLINIC FOR Tamachi, Tokyo, Japan.
  • Arioka H; KARADA Internal Medicine Clinic, Tokyo, Japan.
  • Uehara Y; Chubachi Internal Respiratory Medicine Clinic, Tokyo, Japan.
  • Ihara G; Department of Pediatrics, Showa General Hospital, Tokyo, Japan.
  • Kato Y; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.
  • Yanagisawa N; Department of General Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.
  • Nagura Y; Department of Clinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
  • Yanai H; Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.
  • Ueda A; Machida Ekimae Naika Clinic, Tokyo, Japan.
  • Numata A; Department of Infectious Diseases, International University of Health and Welfare Narita Hospital, Chiba, Japan.
  • Kato H; Yanagisawa Clinic, Tokyo, Japan.
  • Oka H; Shinjuku Home Clinic, Tokyo, Japan.
  • Nishida Y; Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
  • Ooki T; Department of Infectious Diseases, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Nidaira Y; Ikebukuro Metropolitan Clinic, Tokyo, Japan.
  • Stucky A; Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan.
  • Suzuki T; Department of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
  • Smith C; Department of General Internal Medicine and Infectious Diseases, Saitama Medical Center, Saitama, Japan.
  • Hibberd M; Saitama Sekishinkai Hospital, Saitama, Japan.
  • Ariyoshi K; Kuramochi Clinic Interpark, Tochigi, Japan.
  • Suzuki M; Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Euro Surveill ; 28(4)2023 01.
Article em En | MEDLINE | ID: mdl-36700869

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Assunção de Riscos / Vacinas contra COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Assunção de Riscos / Vacinas contra COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão